title: Adolescent bulimia nervosa.
abstract: Onset of bulimia nervosa (BN) typically occurs in adolescence and is frequently accompanied by medical and psychiatric sequelae that may have detrimental effects on adolescent development. Potentially serious medical consequences and high comorbid rates of mood disorders and suicidality underscore the need for early recognition and effective treatments. Research among adolescents with BN has lagged behind that of adults, although evidence is accumulating to support the efficacy of family-based interventions and cognitive behavioral treatments that are adapted for use with adolescent populations. The aim of the current article is to provide an overview of recent research on epidemiology, risk factors, diagnostic issues, and treatment interventions focusing on adolescent BN, and to highlight areas for future research.
authors.affiliation: Psychiatry and Behavioral Neuroscience, The University of Chicago, 5841 S. Maryland Avenue, MC 3077, Chicago, IL 60637, USA. rhoste@yoda.bsd.uchicago.edu
authors.forename: Renee Rienecke
authors.initials: RR
authors.lastname: Hoste
authors.forename: Zandre
authors.initials: Z
authors.lastname: Labuschagne
authors.forename: Daniel
authors.initials: D
authors.lastname: Le Grange
mesh_terms: D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D052018:Bulimia Nervosa / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D039721:Diagnostic and Statistical Manual of Mental Disorders; D006801:Humans; D011613:Psychotherapy / Q000379:methods; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D018687:Antidepressive Agents, Second-Generation